Collaborating to clobber COVID-19
NIH and FNIH are leading a public-private parternship to defeat COVID-19
An overlapping set of collaborations is focusing the combined intellectual, logistic and economic resources of the life sciences industry, government, academia and non-profits against SARS-Cov2, the virus that causes COVID-19.
The latest and broadest collaboration was disclosed Friday when NIH and the Foundation for the NIH (FNIH) announced Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), a public-private partnership to coordinate and accelerate the development of medical countermeasures. ...